Articles tagged with Protein Activation
Researchers discovered Crag's crucial role in maintaining photoreceptor integrity by regulating the trafficking of rhodopsin. The protein activates Rab11, which enables the transport of vesicles loaded with freshly made rhodopsin, resetting the light-sensing mechanism.
Researchers found that eggs that don't fertilise due to defective PLCz protein can be treated with human PLCz, initiating fertilisation and improving pregnancy chances. The study strengthens potential use of PLCz in treating male infertility.
Researchers at Aarhus University have determined the atomic structures of MASP-2 and its substrate C4, shedding light on the complement system's activation process. The findings may lead to more intelligent ways of developing drugs that attenuate undesired activation of the complement system.
A UNC-led team describes a previously uncharacterized protein NLRC3 that inhibits NF-Kappa B activation and forms a novel TRAFasome complex. This discovery provides insight into mechanisms controlling inflammation and identifies potential therapeutic targets.
Researchers at OHSU School of Dentistry discovered that TDP-43, linked to ALS and other neurodegenerative diseases, activates multiple molecular pathways when genetically manipulated. The study found that the loss of TDP-43 results in widespread gene activation and altered splicing, which can be reversed by restoring TDP-43 expression.
Scientists have identified a new protein function that protects heart cells from damage during extreme hypertension and cardiac pressure overload. The discovery could lead to the development of treatments for conditions like cardiovascular disease and Alzheimer's.
Researchers have identified a prototype compound that can directly activate the BAX protein, leading to apoptosis in cancer cells. This new paradigm for designing cancer drugs may lead to new therapeutic strategies.
A new study suggests that a protein called heat shock factor-1 (HSF-1) is involved in chemotherapy-related heart damage. Researchers propose targeting HSF-1 in the heart as a potential therapy to prevent cardiac damage, potentially leading to improved outcomes for cancer patients undergoing chemotherapy.
Researchers at the University of Cambridge have identified a protein called BMP8B that regulates brown fat activation in both brain and body tissues. Activating this protein may help support weight loss programs and prevent metabolic rate decrease.
Researchers shed light on how physical traits are arranged in body plans by studying fruit fly Drosophila. They found that a single gradient of proteins is not sufficient to form the same body plan in each member of a species, but multiple gradients working against each other create a robust system for normal development.
Researchers at Baylor College of Medicine discover that ROCK1 protein activates mitochondrial fission, leading to diabetic kidney disease. The study reveals a key metabolic pathway involved in the progression of kidney disease in diabetes.
Researchers at Ruhr-University Bochum found that sildenafil, the active ingredient in Viagra, makes stiffened cardiac walls more elastic. The drug activates an enzyme that phosphorylates the giant protein titin, causing blood vessels to relax and improving diastolic distensibility.
Scientists have made a breakthrough in understanding how the EDS1 protein, a central component of plant defense, interacts with other proteins to activate an immune response. The study reveals that EDS1 is attacked by virulence proteins from pathogens and triggers the activation of distinct immune responses to isolate the infection.
Researchers at Caltech found that bacterial cells respond to stress by continuously flipping genes on and off, similar to a heater switching on and off. This pulsating mechanism, triggered by molecular fluctuations, could drive other cellular processes and reveal more about how life works.
Researchers found that green vegetables stimulate a key immune system function by regulating cell surface proteins in the gut and skin. This helps maintain healthy intra-epithelial lymphocytes (IELs), which are crucial for fighting off infections.
Researchers have identified a way to reduce beta-amyloid in mouse brains with AD, suggesting that activating ABCC1 transport protein could impede amyloid plaque formation. The approach uses thiethylperazine to activate ABC transporters and has potential for treating Alzheimer's disease.
A researcher is investigating the factor that initiates the immune system's overreaction after a traumatic event. The goal is to interrupt this chain of events and prevent unnecessary cell death in the intestines.
Researchers discovered a link between cell rigidity and proteins associated with cancer activity, using innovative collaboration between physics and cell biology. Exerting mechanical force on cells activates Rho GEF proteins, leading to tumor growth and metastasis.
Scientists have identified a molecular sensor of temperature within immune cells, which primes the immune response to temperature shifts. This discovery could provide new insights into the mechanisms underlying fever and its effects on the immune system.
Activation of CTNNB1 biomarker is associated with better survival rates among obese patients with colorectal cancer, while physical activity improves survival for those without CTNNB1 activation. The study suggests a possible interactive effect between tumor CTNNB1 signaling and energy balance status on tumor cell behavior.
Researchers identify a key process leading to brain cell death in Parkinson's disease, offering hope for slowing progression and diagnosis. Blocking this process preserves parkin function and spares neurons.
Scientists have discovered that anaphylatoxin C5a contributes to the development of atherosclerotic disease by causing plaques to break free and block blood vessels. Inhibiting C5a may provide a new therapeutic tool for preventing heart attacks and strokes.
Researchers have identified a mechanism that could explain why flu infections may help prevent asthma in children. Infection with influenza A virus protects mice from asthma by expanding NKT cells, which are immune cells that play a key role in the body's response to infection.
Researchers at Johns Hopkins Medicine have discovered a new regulatory protein, GAKIN, that oversees the activity of CARD11, a key player in immune cell activation. This finding presents opportunities to develop new treatments for autoimmune diseases and cancer by targeting hyperactive immune cells.
A study has identified two key signaling pathways - Ras/MAPK and Rac/Stat3 - that are activated in the hearts of mice with a Noonan syndrome-associated Sos1 mutation. These pathways may be crucial for understanding the development of heart defects in individuals with the disorder.
Researchers at Temple University discovered that STIM1 protein inhibits voltage-operated calcium channels in non-excitable cells, providing a common mechanism for calcium signaling in both types of cells. This finding reveals a crucial role of STIM1 in sensing low calcium levels and activating Orai channels.
Research finds key gene expression pathways involved in Candidiasis-associated denture stomatitis, with significant up-regulation of TLR2 and CD28 signaling. Saliva analysis reveals six extracellular protein genes linked to stomatitis.
Scientists discover A20 protein plays a protective role in chronic bowel inflammation, making it a promising therapeutic target. The study confirms genome-wide analysis results showing defects in A20 associated with Crohn's disease development.
Researchers found that p53 is activated during the formation of spermatozoa and ova, controlling the creation of gametes to prevent mutations. This discovery suggests a new role for the tumour suppressor gene in evolution, potentially leading to new approaches in cancer research.
Researchers at Scripps Research and GNF identify a region of TRPV1 protein that enables temperature sensitivity, shedding light on how temperature receptors work in the human body. The findings could lead to new therapies for conditions such as inflammatory pain.
A physics strategy called resonant activation is being tested as a solution for antibiotic resistance, targeting dormant persister cells. The approach involves repetitive antibiotic treatment to accelerate sterilization of bacterial colonies.
Researchers expanded a method to move proteins inside cells to specific organelles, enabling rapid manipulation of protein activities. By studying the signaling protein Ras, they gained insights into how proteins contribute to cellular responses and signal division and growth.
Researchers use a novel light activation technique to turn modest molecules into powerful protein destroyers, expanding the search for new therapies. The new technique, CALI, uses a 'warhead' molecule capable of inactivating nearby proteins when triggered by light.
A new study reveals that HLA B*35-Px molecules cripple killer T cell responses, allowing HIV to progress more rapidly. This finding highlights the importance of inhibitory dendritic cell receptors in HIV-1 vaccine and therapy design.
Scientists have discovered that the protein PARP-1 plays a crucial role in activating the transcription factor NF-kappaB, which triggers a survival program that blocks programmed cell death. This activation is thought to be one of the potential causes for tumor cell resistance to chemotherapy and radiation therapy.
A study found that protein interaction networks respond to Helicobacter pylori infection by activating immune-related proteins and interacting with cancer-related proteins. The network construction reveals potential drug targets for gastric inflammation and cancer, including hub and bottleneck proteins.
A harmless shard from a childhood virus's shell may halt the complement response, a primordial part of the immune system that kills oxygen-deprived victims. This discovery could help save soldiers' lives and reduce brain damage caused by reperfusion injury.
Researchers at Carnegie Mellon University have identified a key regulatory gene network that plays a crucial role in the spread of common and deadly yeast infections. The study reveals how the Zap1 protein regulates biofilm matrix production, which helps pathogens thrive and resist treatment.
Researchers at Carnegie Mellon University have identified a novel regulatory gene network that plays a crucial role in the spread of invasive yeast infections. The study reveals that Zap1 protein regulates the production of biofilm matrix, promoting infection and drug resistance.
A team of researchers developed an antibody targeting FGFR3, which showed potent antitumor activity against human bladder cancer cells and t(4;14)-positive multiple myeloma cells. The antibody also demonstrated activity against normal FGFR3 and mutated forms associated with cancer.
Researchers at UC San Diego School of Medicine identified CD98hc protein as essential for B lymphocyte division and antibody secretion. The protein supports integrin signaling, which controls cell migration, survival, and proliferation.
Researchers have identified a crucial biochemical step involved in nerve cells' response to DNA damage. Cdk5 activation is necessary before ATM can function in neurons, suggesting it as a potential drug target for neurodegenerative diseases. This discovery sheds light on the underlying mechanisms of ataxia telangiectasia and other neur...
Researchers have identified a new genetic cause of severe combined immunodeficiency (SCID), also known as 'Boy in the bubble syndrome'. A mutation in the DNA-PKcs gene has been found to be associated with T-B SCID, where patients lack both T and B cells. Further analysis revealed that the mutant protein retained kinase activity but was...
Researchers found that fecal levels of FC and MPO can be used as surrogate markers for successful treatment outcome in IBD patients. The study also showed that elevated fecal markers are associated with relapse, but normalized FC level may indicate successful treatment.
Researchers identified eEF2K as a key player in enabling the rapid production of Arc protein, crucial for long-term memory formation. The paradoxical mechanism involves eEF2K inhibiting protein translation while also facilitating Arc protein synthesis.
A new study found that targeting liver CB1 receptor may treat obesity-related conditions without brain-side effects, reversing severe insulin resistance and fatty liver in mice fed high-fat diets. The research indicates liver-specific CB1 is necessary for high-fat diet-induced fatty liver and related hormonal changes.
Researchers have discovered that hyperactive immune resistance contributes to age-dependent macular degeneration (AMD), the leading cause of blindness in Western countries. The study found that patients with AMD had an entire immune system hyperactive, which may lead to permanent inflammation and vision loss.
Researchers have discovered that Properdin, a protein linked to defence against meningitis, plays a more vital role than previously understood in the body's immune defence system. The study also found that Properdin can aggravate organ damage in certain conditions.
Researchers have created fluorogen activating proteins (FAPs) that enable biologists to monitor biological activities of individual proteins in living cells in real time. The FAPs allow for simple and direct tracking of proteins on the cell surface and within living cells, eliminating cumbersome experimental steps.
A protein called macrophage migration inhibitory factor (MIF) has been found to activate AMPK, a key regulator of cellular energy balance, protecting the heart from injury during a heart attack. MIF may help identify individuals at higher risk for cardiac damage during a heart attack based on their genetic characteristics.
Research finds that elite rowers show a significant reduction in lactoferrin concentration after five months of sedentary lifestyle, but experience an increase in salivary proteins following moderate and high-intensity exercise. This study aims to test the effectiveness of nutritional interventions on the immune system.
Researchers at Helmholtz Munich have found that ubiquitin attaches to Malt1 protein in T cells upon antigen stimulation, regulating immune defense. This process is reversible and helps prevent over-activation of T cells, a common cause of chronic diseases.
Mercury has been shown to activate phospholipase D enzyme in cells lining blood vessels, causing damage and contributing to vascular disorders. Chelation therapy and antioxidants have been found to suppress this activity, suggesting potential preventive measures against mercury-induced cardiovascular disease.
Researchers identified a new protein involved in egg activation and its role in fertilization. A chemical has been found effective against anthrax by blocking spore germination. A new protein also controls the growth of the hepatitis C virus, which could lead to new drug development.
Researchers identify crucial role of RhoH GTPase in development and activation of white blood cells, suggesting potential target for leukemia treatment. The study's findings may provide a novel approach to treating hematological malignancy.
Researchers have identified a protein called TRPM8 that mediates sensations of coolness and is expressed in nerve cells in the skin, responding to both cool temperatures and cooling chemicals like mint oil. This discovery has great potential for relieving chronic pain patients with approaches using cooling compounds
Researchers found that restoring Ras-GAP activity through expression of the human NF1 GAP-related domain restored normal cardiac development in mice with Neurofibromatosis type I disease. However, this approach did not fully restore all pathologies associated with neurofibromin loss, indicating a more complex role for the protein.
A study by William D. Toff and colleagues found no significant difference in markers of coagulation activation between long-haul flights and controlled environments. The researchers tested the effects of hypobaric and hypoxia on healthy volunteers, but found that prolonged sitting did not enhance clot formation.
Researchers at Scripps Research Institute have discovered small molecule activators of botulinum neurotoxin (BoNT), which could minimize dosage and reduce resistance. The findings hold promise for increasing the clinical efficacy of BoNT, a toxin with a range of therapeutic uses.
Researchers identified issues with commonly used anti-PKC-delta antibodies that affect immunoblotting studies of phosphoproteins. This limitation may lead to misinterpretation of PKC-delta expression levels in heart cells.